Literature DB >> 1092424

Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.

B A Wood, A M Monro.   

Abstract

Serum concentrations of tinidazole and metronidazole have been measured in healthy female volunteers who received a single dose of 2 g. of each drug in a cross-over study. Bioassays against T. vaginalis showed that metronidazole achieved higher peak concentrations (mean 81 mug./ml.) than did tinidazole (mean 67 mug./ml.), while assays for unchanged drug showed higher peak concentrations of tinidazole )mean 51 mug./ml;) than of metronidazole (mean 40 mug./ml9). This discrepancy is probably due to the presence in the serum of active metabolites of metronidazole. The longer half-life of tinidazole led to significantly higher serum concentrations (by bioassay and chemical assay) of tinidazole than of metronidazole from 6 hrs onwards.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092424      PMCID: PMC1045111          DOI: 10.1136/sti.51.1.51

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  8 in total

1.  Tinidazole--a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose.

Authors:  J Wallin; A Forsgren
Journal:  Br J Vener Dis       Date:  1974-04

2.  Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation.

Authors:  A Forsgren; J Wallin
Journal:  Br J Vener Dis       Date:  1974-04

3.  Treatment of trichomoniasis in the female with a single dose of tinidazole.

Authors:  G W Rösemann; J Vaughan
Journal:  S Afr Med J       Date:  1973-07-21

4.  The pharmacokinetics of metronidazole and tinidazole in man.

Authors:  P G Welling; A M Monro
Journal:  Arzneimittelforschung       Date:  1972-12

5.  Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa.

Authors:  H L Howes; J E Lynch; J L Kivlin
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

6.  Tinidazole and metronidazole pharmocokinetics in man and mouse.

Authors:  J A Taylor; J R Migliardi; M S Von Wittenau
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

7.  The isolation and identification of the urinary oxidative metabolites of metronidazole in man.

Authors:  J E Stambaugh; L G Feo; R W Manthei
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

8.  Trichomonal vaginitis treated with one dose of metronidazole.

Authors:  G W Csonka
Journal:  Br J Vener Dis       Date:  1971-12
  8 in total
  26 in total

Review 1.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Secnidazole. A 5-nitroimidazole derivative with a long half-life.

Authors:  D Videau; G Niel; A Siboulet; F Catalan
Journal:  Br J Vener Dis       Date:  1978-04

4.  Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men.

Authors:  N Kawamura
Journal:  Br J Vener Dis       Date:  1978-04

Review 5.  Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.

Authors:  Jenell S Coleman; Charlotte A Gaydos; Frank Witter
Journal:  Obstet Gynecol Surv       Date:  2013-01       Impact factor: 2.347

Review 6.  Aspects of the pharmacology and pharmacokinetics of nitroimidazoles with special reference to tinidazole.

Authors:  Y Noguchi; T Tanaka
Journal:  Drugs       Date:  1978       Impact factor: 9.546

7.  Tinidazole and metronidazole in hepatic amoebiasis.

Authors:  N Islam; K Hasan
Journal:  Drugs       Date:  1978       Impact factor: 9.546

8.  Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.

Authors:  B L Flouvat; C Imbert; D M Dubois; B P Temperville; A F Roux; G C Chevalier; G Humbert
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

9.  Influence of dose and route of administration on disposition of metronidazole and its major metabolites.

Authors:  S Loft; M Døssing; H E Poulsen; J Sonne; K L Olesen; K Simonsen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.